{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:31:52Z","timestamp":1791325912320,"version":"4.3.1"},"reference-count":149,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00037","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T07:43:27Z","timestamp":1486971807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":357,"title":["Exploring Braak\u2019s Hypothesis of Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Carmen D.","family":"Rietdijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Perez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J. A.","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta D.","family":"Kraneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","article-title":"Prevalence and incidence of Parkinson\u2019s disease in Europe","volume":"15","author":"von Campenhausen","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries","volume":"34","author":"Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mds.26102","article-title":"The medical treatment of Parkinson disease from James Parkinson to George Cotzias","volume":"30","author":"Fahn","year":"2015","journal-title":"Mov Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease","volume":"28","author":"Warren Olanow","year":"2013","journal-title":"Mov Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nn.4007","article-title":"Good vibrations with deep brain stimulation","volume":"18","author":"Williams","year":"2015","journal-title":"Nat Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel alpha-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson\u2019s disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"key":"B18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/1531-8249(199905)45:5577::AID-ANA53.0.CO;2-O","article-title":"The role of inheritance in sporadic Parkinson\u2019s disease: evidence from a longitudinal study of dopaminergic function in twins","volume":"45","author":"Piccini","year":"1999","journal-title":"Ann Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1923.e1","DOI":"10.1016\/j.neurobiolaging.2011.02.017","article-title":"Heritability of Parkinson disease in Swedish twins: a longitudinal study","volume":"32","author":"Wirdefeldt","year":"2011","journal-title":"Neurobiol Aging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2047-9158-3-10","article-title":"Considerations on the role of environmental toxins in idiopathic Parkinson\u2019s disease pathophysiology","volume":"3","author":"Pan-Montojo","year":"2014","journal-title":"Transl Neurodegener"},{"key":"B22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2012.07.002","article-title":"Inflammation and neurodegeneration: the story \u201cretolled\u201d","volume":"33","author":"Drouin-Ouellet","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","article-title":"Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease\u2014is there a link?","volume":"47","author":"Tom\u00e9","year":"2013","journal-title":"Mol Neurobiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/mds.25979","article-title":"Enteric glial cells: new players in Parkinson\u2019s disease?","volume":"30","author":"Clairembault","year":"2015","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease and Parkinson\u2019s disease: are microglia pathogenic in either disorder?","volume":"82","author":"Rogers","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol Neurobiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/108029","article-title":"Mitochondrial dysfunction and-synuclein synaptic pathology in Parkinson\u2019s disease: who\u2019s on first?","volume":"2015","author":"Zaltieri","year":"2015","journal-title":"Park Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm (Vienna)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson\u2019s disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: sporadic Parkinson\u2019s disease: development and distribution of \u03b1-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","article-title":"Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"46","author":"Cersosimo","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.nbd.2011.10.026","article-title":"Olfaction in Parkinson\u2019s disease and related disorders","volume":"46","author":"Doty","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","article-title":"Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol (Berl)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1469-7580.2007.00748.x","article-title":"Alpha-synuclein pathology in the olfactory pathways of dementia patients","volume":"211","author":"Hubbard","year":"2007","journal-title":"J Anat"},{"key":"B41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol (Berl)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"B43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","article-title":"\u03b1-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects","volume":"32","author":"Bloch","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mds.21560","article-title":"Bowel movement frequency in late-life and incidental Lewy bodies","volume":"22","author":"Abbott","year":"2007","journal-title":"Mov Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/mds.21076","article-title":"Association of olfactory dysfunction with incidental Lewy bodies","volume":"21","author":"Ross","year":"2006","journal-title":"Mov Disord"},{"key":"B49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson\u2019s disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol (Berl)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","article-title":"Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits","volume":"47","author":"Hallett","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","article-title":"Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes","volume":"19","author":"Kuo","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson\u2019s disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","article-title":"MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut","volume":"1355","author":"Natale","year":"2010","journal-title":"Brain Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J Neurosci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"B60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson\u2019s disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","journal-title":"Neurobiol Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2012.06.005","article-title":"Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system","volume":"48","author":"Noorian","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Mov Disord"},{"key":"B63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"B64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6ra14","DOI":"10.1126\/scitranslmed.3000322","article-title":"The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice","volume":"1","author":"Turnbaugh","year":"2009","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5740\/jaoacint.SGEWong","article-title":"Gut microbiota, diet, and heart disease","volume":"95","author":"Wong","year":"2012","journal-title":"J AOAC Int"},{"key":"B68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1017\/S0007114508094658","article-title":"Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations","volume":"101","author":"Brinkworth","year":"2009","journal-title":"Br J Nutr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"De Filippo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B71","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ijo.2012.33","article-title":"The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome \u201cat-risk\u201d population","volume":"37","author":"Fava","year":"2013","journal-title":"Int J Obes 2005"},{"key":"B72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/pri.23582","article-title":"The pathology roadmap in Parkinson disease","volume":"7","author":"Surmeier","year":"2013","journal-title":"Prion"},{"key":"B73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-008-0355-5","article-title":"A not entirely benign procedure: progression of Parkinson\u2019s disease","volume":"115","author":"Del Tredici","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease","volume":"119","author":"Del Tredici","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF00369454","article-title":"Parkinson\u2019s disease with involvement of the parasympathetic ganglia","volume":"86","author":"Takeda","year":"1993","journal-title":"Acta Neuropathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","article-title":"Lewy body-related \u03b1-synucleinopathy in the aged human brain","volume":"111","author":"Jellinger","year":"2004","journal-title":"J Neural Transm"},{"key":"B78","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1212\/WNL.42.11.2106","article-title":"Age-related loss of dorsal vagal neurons in Parkinson\u2019s disease","volume":"42","author":"Gai","year":"1992","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/srep00898","article-title":"Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice","volume":"2","author":"Pan-Montojo","year":"2012","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: a second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Mov Disord"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/mds.23012","article-title":"Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson\u2019s disease","volume":"25","author":"Li","year":"2010","journal-title":"Mov Disord"},{"key":"B89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2009.05229.x","article-title":"Lewy body pathology in fetal grafts","volume":"1184","author":"Chu","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JPD-2011-11004","article-title":"Signs of degeneration in 12\u201322-year old grafts of mesencephalic dopamine neurons in patients with Parkinson\u2019s disease","volume":"1","author":"Kurowska","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B92","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.nbd.2011.05.001","article-title":"Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat","volume":"43","author":"Kordower","year":"2011","journal-title":"Neurobiol Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"B95","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol Neurodegener"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular a-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1046\/j.1460-9568.1999.00754.x","article-title":"Axonal transport of synucleins is mediated by all rate components","volume":"11","author":"Jensen","year":"1999","journal-title":"Eur J Neurosci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","article-title":"Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport","volume":"72","author":"Freundt","year":"2012","journal-title":"Ann Neurol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"6307","key":"B102","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3374","article-title":"Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2003.04.001","article-title":"Poor and protracted myelination as a contributory factor to neurodegenerative disorders","volume":"25","author":"Braak","year":"2004","journal-title":"Neurobiol Aging"},{"key":"B104","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson\u2019s disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur J Neurosci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2051-5960-1-2","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"1","author":"Visanji","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"B106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1074\/jbc.M310994200","article-title":"Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective","volume":"279","author":"Tanaka","year":"2004","journal-title":"J Biol Chem"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.bbamem.2015.01.018","article-title":"Interactions between misfolded protein oligomers and membranes: a central topic in neurodegenerative diseases?","volume":"1848","author":"Andreasen","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B109","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting \u03b1-synuclein protofibrils reduced pathology in (Thy-1)-h [A30P] \u03b1-synuclein mice","volume":"69","author":"Lindstr\u00f6m","year":"2014","journal-title":"Neurobiol Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"B111","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B112","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","article-title":"Prion-like acceleration of a synucleinopathy in a transgenic mouse model","volume":"33","author":"Mougenot","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B114","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","article-title":"Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of Parkinsonism","volume":"10","author":"Osterberg","year":"2015","journal-title":"Cell Rep"},{"key":"B116","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann Neurol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2990.2008.00998.x","article-title":"Evidence against a reliable staging system of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"35","author":"Kalaitzakis","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of \u03b1-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease","volume":"34","author":"Attems","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of \u03b1-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s and Alzheimer\u2019s disease brain: incidence and topographic distribution \u2013 a pilot study","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"MRC Cognitive Function ANS. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.23305","article-title":"Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model","volume":"25","author":"Kingsbury","year":"2010","journal-title":"Mov Disord"},{"key":"B126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JPD-2011-11061","article-title":"Colonic neuropathology is independent of olfactory dysfunction in Parkinson\u2019s disease","volume":"1","author":"Lebouvier","year":"2011","journal-title":"J Park Dis"},{"key":"B127","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","article-title":"Regional distribution of \u03b1-synuclein pathology in unimpaired aging and Alzheimer disease","volume":"62","author":"Parkkinen","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"\u03b1-Synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann Neurol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0381-3","article-title":"Controversies over the staging of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"116","author":"Kalaitzakis","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","article-title":"Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra","volume":"63","author":"Greffard","year":"2006","journal-title":"Arch Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JPD-2011-11046","article-title":"Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson\u2019s disease","volume":"1","author":"Parkkinen","year":"2011","journal-title":"J Park Dis"},{"key":"B135","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-014-0090-1","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"B136","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10072-012-1106-x","article-title":"TLR9-1237 T\/C and TLR2-194 to -174 del polymorphisms and the risk of Parkinson\u2019s disease in the Greek population: a pilot study","volume":"34","author":"Kalinderi","year":"2013","journal-title":"Neurol Sci"},{"key":"B137","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2222.2004.01839.x","article-title":"An association study of asthma and total serum immunoglobin E levels for toll-like receptor polymorphisms in a Japanese population","volume":"34","author":"Noguchi","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"B138","doi-asserted-by":"publisher","first-page":"yu103","DOI":"10.1093\/ijnp\/pyu103","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson\u2019s disease","volume":"18","author":"Drouin-Ouellet","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1038\/emm.2014.6","article-title":"\u03b21-Integrin-dependent migration of microglia in response to neuron-released \u03b1-synuclein","volume":"46","author":"Kim","year":"2014","journal-title":"Exp Mol Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/WNR.0000000000000406","article-title":"Elevated neuronal \u03b1-synuclein promotes microglia activation after spinal cord ischemic\/reperfused injury","volume":"26","author":"Qiao","year":"2015","journal-title":"Neuroreport"},{"key":"B141","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci Signal"},{"key":"B142","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2011.00080","article-title":"alpha-Synuclein alters toll-like receptor expression","volume":"5","author":"Beraud","year":"2011","journal-title":"Front Neurosci"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e79160","DOI":"10.1371\/journal.pone.0079160","article-title":"Preconditioning of microglia by \u03b1-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation","volume":"8","author":"Roodveldt","year":"2013","journal-title":"PLoS One"},{"key":"B144","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1073\/pnas.1432609100","article-title":"Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway","volume":"100","author":"Lehnardt","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B145","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am J Pathol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"B147","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","article-title":"Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes","volume":"16","author":"Rannikko","year":"2015","journal-title":"BMC Neurosci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","volume":"3","author":"Noelker","year":"2013","journal-title":"Sci Rep"},{"key":"B149","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","article-title":"Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy","volume":"13","author":"Kim","year":"2015","journal-title":"Cell Rep"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T07:43:27Z","timestamp":1486971807000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":149,"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00037","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}